Renaissance Technologies’s ProQR Therapeutics PRQR Stock Holding History

Renaissance Technologies’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-200,499	Closed	-$325K	–	4007
2023 Q2	$325K	Buy	+200,499	New	+$392K	﹤0.01%	3096
2022 Q4	–	Sell	-590,568	Closed	-$439K	–	4334
2022 Q3	$439K	Sell	590,568 -338,432	-36%	-$272K	﹤0.01%	3002
2022 Q2	$722K	Buy	929,000 +324,819	+54%	+$242K	﹤0.01%	2915
2022 Q1	$547K	Buy	+604,181	New	+$2.02M	﹤0.01%	3126
2021 Q1	–	Sell	-335,300	Closed	-$1.41M	–	3618
2020 Q4	$1.41M	Buy	335,300 +194,300	+138%	+$820K	﹤0.01%	2324
2020 Q3	$675K	Sell	141,000 -4,700	-3%	-$24.6K	﹤0.01%	2703
2020 Q2	$886K	Buy	145,700 +108,700	+294%	+$587K	﹤0.01%	2597
2020 Q1	$203K	Sell	37,000 -46,000	-55%	-$353K	﹤0.01%	3099
2019 Q4	$823K	Sell	83,000 -19,300	-19%	-$150K	﹤0.01%	2717
2019 Q3	$589K	Buy	102,300 +84,500	+475%	+$675K	﹤0.01%	2810
2019 Q2	$162K	Buy	17,800 +2,500	+16%	+$29.5K	﹤0.01%	3336
2019 Q1	$212K	Buy	+15,300	New	+$228K	﹤0.01%	3200
2016 Q3	–	Sell	-13,000	Closed	-$63K	–	3462
2016 Q2	$63K	Buy	+13,000	New	+$66.9K	﹤0.01%	3215
2015 Q3	–	Sell	-14,697	Closed	-$245K	–	3319
2015 Q2	$245K	Buy	+14,697	New	+$277K	﹤0.01%	2939

Other funds holding PRQR

PFM

Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies's PRQR Position: Q3 2023 in Review

Renaissance Technologies sold out of ProQR Therapeutics (PRQR) in Q3 2023, closing a stake of 200,499 shares — an estimated $325K sold.

Renaissance Technologies first reported a position in PRQR in Q2 2015 and held it in 14 quarters. The position peaked at $1.41M in Q4 2020. 46 funds tracked by Wall St. Rank hold PRQR as of Q3 2023.

Renaissance Technologies reported no remaining ProQR Therapeutics position as of Q3 2023 after selling out during the quarter.
Renaissance Technologies sold 200,499 ProQR Therapeutics shares in Q3 2023, an estimated $325K.
Renaissance Technologies first reported a position in ProQR Therapeutics in Q2 2015 and held it in 14 quarters.
Renaissance Technologies's ProQR Therapeutics position peaked at $1.41M in Q4 2020.
46 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.